Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Hansson

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Blood|May 3, 2012
Monocytic AML cells inactivate antileukemic lymphocytes: role of NADPH oxidase/gp91(phox) expression and the PARP-1/PAR pathway of apoptosisJohan Aurelius, Fredrik B Thorén, Ali A Akhiani, et al.
Plos One|February 4, 2017
A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myelomaStina Wichert, Gunnar Juliusson, Åsa Johansson, et al.
European Journal of Haematology|August 3, 2023
Epidemiology and clinical outcomes of light-chain amyloidosis in Sweden: A nationwide population-based studyUlf-Henrik Mellqvist, Qian Cai, Laura L Hester, et al.
Blood|January 4, 2014
Robust isolation of malignant plasma cells in multiple myelomaIldikó Frigyesi, Jörgen Adolfsson, Mina Ali, et al.
Cancer Medicine|April 23, 2024
Effectiveness and infectious complications of BCMA T-cell engagers in treating multiple myeloma: Real-world evidence from SwedenKatarina Uttervall, Love Tätting, Konstantinos Lemonakis, et al.
Journal of Leukocyte Biology|March 16, 2017
NOX2-dependent immunosuppression in chronic myelomonocytic leukemiaJohan Aurelius, Alexander Hallner, Olle Werlenius, et al.
Oncotarget|November 7, 2015
Genetic and epigenetic characterization of hypodiploid acute lymphoblastic leukemiaSetareh Safavi, Linda Olsson, Andrea Biloglav, et al.
Acta Haematologica|February 25, 2021
Burden of Treatment-Induced Peripheral Neuropathy in Patients with Multiple Myeloma in SwedenHareth Nahi, Göran Walinder, Vishal Patel, et al.
Journal of Patient-Reported Outcomes|February 5, 2024
Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma: a randomized phase 2 trial by the Nordic Myeloma Study GroupLene Kongsgaard Nielsen, Fredrik Schjesvold, Sören Möller, et al.
Ejhaem|June 19, 2024
The choice of serum-free light chain analysis method could potentially have clinical consequences for myeloma patientsLjupco Veskovski, Ingvar Jakobsson, Per-Ola Andersson, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Blood|May 3, 2012
Monocytic AML cells inactivate antileukemic lymphocytes: role of NADPH oxidase/gp91(phox) expression and the PARP-1/PAR pathway of apoptosisJohan Aurelius, Fredrik B Thorén, Ali A Akhiani, et al.
Plos One|February 4, 2017
A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myelomaStina Wichert, Gunnar Juliusson, Åsa Johansson, et al.
European Journal of Haematology|August 3, 2023
Epidemiology and clinical outcomes of light-chain amyloidosis in Sweden: A nationwide population-based studyUlf-Henrik Mellqvist, Qian Cai, Laura L Hester, et al.
Blood|January 4, 2014
Robust isolation of malignant plasma cells in multiple myelomaIldikó Frigyesi, Jörgen Adolfsson, Mina Ali, et al.
Cancer Medicine|April 23, 2024
Effectiveness and infectious complications of BCMA T-cell engagers in treating multiple myeloma: Real-world evidence from SwedenKatarina Uttervall, Love Tätting, Konstantinos Lemonakis, et al.
Journal of Leukocyte Biology|March 16, 2017
NOX2-dependent immunosuppression in chronic myelomonocytic leukemiaJohan Aurelius, Alexander Hallner, Olle Werlenius, et al.
Oncotarget|November 7, 2015
Genetic and epigenetic characterization of hypodiploid acute lymphoblastic leukemiaSetareh Safavi, Linda Olsson, Andrea Biloglav, et al.
Acta Haematologica|February 25, 2021
Burden of Treatment-Induced Peripheral Neuropathy in Patients with Multiple Myeloma in SwedenHareth Nahi, Göran Walinder, Vishal Patel, et al.
Journal of Patient-Reported Outcomes|February 5, 2024
Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma: a randomized phase 2 trial by the Nordic Myeloma Study GroupLene Kongsgaard Nielsen, Fredrik Schjesvold, Sören Möller, et al.
Ejhaem|June 19, 2024
The choice of serum-free light chain analysis method could potentially have clinical consequences for myeloma patientsLjupco Veskovski, Ingvar Jakobsson, Per-Ola Andersson, et al.
Pageof 9